The WHO Pharmaceuticals Newsletter provides you with the latest safety
reports, advice, warnings and other updates from regulatory authorities across
the world, including suspension and new restriction of the use of pioglitazone.
In this edition of the WHO Pharmaceuticals Newsletter, you will also find a
summary of two training courses on pharmacovigilance hosted by the Pharmacy and
Poisons Board, Kenya...